Humacyte logo

Humacyte Share Price Today

(NASDAQ: HUMA)

Humacyte share price is $3.15 & ₹273.95 as on 6 Mar 2025, 2.30 'hrs' IST

$3.15

-0.05

(-1.56%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Humacyte share price in Dollar and Rupees. Guide to invest in Humacyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Humacyte, along with analyst recommendations, forecasts, and comprehensive financials.

Humacyte share price movements

  • Today's Low: $3.02
    Today's High: $3.25

    Day's Volatility :7.08%

  • 52 Weeks Low: $2.81
    52 Weeks High: $9.97

    52 Weeks Volatility :71.82%

Humacyte (HUMA) Returns

PeriodHumacyte IncSector (Health Care)Index (Russel 2000)
3 Months
-29.84%
3.7%
0.0%
6 Months
-42.52%
-2.8%
0.0%
1 Year
-6.53%
2.5%
0.0%
3 Years
-12.5%
12.9%
-11.6%

Humacyte (HUMA) Key Statistics

in dollars & INR

Previous Close
$3.2
Open
$3.21
Today's High
$3.25
Today's Low
$3.02
Market Capitalization
$411.7M
Today's Volume
$2.1M
52 Week High
$9.97
52 Week Low
$2.81
Revenue TTM
$0.0
EBITDA
$-105.3M
Earnings Per Share (EPS)
$-1.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-850.81%

How to invest in Humacyte Stock (HUMA) from India?

It is very easy for Indian residents to invest directly in Humacyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Humacyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Humacyte or HUMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Humacyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Humacyte shares which would translate to 0.276 fractional shares of Humacyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Humacyte, in just a few clicks!

Returns in Humacyte (HUMA) for Indian investors in Rupees

The Humacyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Humacyte investment value today

Current value as on today

₹98,421

Returns

₹1,579

(-1.58%)

Returns from Humacyte Stock

₹6,528 (-6.53%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Humacyte (HUMA)

-43%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Humacyte Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Humacyte

  • BlackRock Inc

    6.25%

  • Vanguard Group Inc

    4.35%

  • State Street Corp

    3.58%

  • Woodline Partners LP

    2.21%

  • Geode Capital Management, LLC

    1.66%

  • CenterBook Partners LP

    0.99%

Analyst Recommendation on Humacyte

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Humacyte(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Humacyte Stock (HUMA)

What analysts predicted

Upside of 317.23%

Target:

$13.14

Current:

$3.15

Insights on Humacyte Stock (Ticker Symbol: HUMA)

  • Price Movement

    In the last 7 days, HUMA stock has moved down by -6.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 31.0K → 10.79M (in $), with an average increase of 99.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -56.66M → -39.20M (in $), with an average increase of 44.5% per quarter
  • HUMA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 73.0%

Humacyte Technicals Summary

Sell

Neutral

Buy

Humacyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Humacyte (HUMA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Humacyte Inc logo
-27.92%
-42.52%
-6.53%
-12.5%
-12.5%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Humacyte Inc logo
1.0
NA
NA
-1.27
-8.51
-0.53
NA
-0.53
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Humacyte Inc logo
Buy
$411.7M
-12.5%
1.0
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Humacyte

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Organization
Humacyte
Employees
183
CEO
Dr. Laura E. Niklason M.D., Ph.D.
Industry
Healthcare

Management People of Humacyte

NameTitle
Dr. Laura E. Niklason M.D., Ph.D.
Founder, President, CEO & Director
Mr. Dale A. Sander
CFO, Chief Corporate Development Officer & Treasurer
Dr. Heather Ledbetter Prichard Ph.D.
Chief Operating Officer
Ms. Sabrina Osborne GPHR, SPHR
Chief People Officer
Mr. William John Scheessele
Chief Commercial Officer
Dr. Shamik J. Parikh M.D.
Chief Medical Officer
Mr. Harold Alterson
Chief Quality Officer
Dr. Yang Cao M.D., Ph.D.
Chief Regulatory Officer

Important FAQs about investing in HUMA Stock from India :

What is Humacyte share price today?

Humacyte share price today stands at $3.15, Open: $3.21 ; Previous Close: $3.20 ; High: $3.25 ; Low: $3.02 ; 52 Week High: $9.97 ; 52 Week Low: $2.81.

The stock opens at $3.21, after a previous close of $3.20. The stock reached a daily high of $3.25 and a low of $3.02, with a 52-week high of $9.97 and a 52-week low of $2.81.

Can Indians buy Humacyte shares?

Yes, Indians can invest in the Humacyte (HUMA) from India.

With INDmoney, you can buy Humacyte at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Humacyte at zero transaction cost.

How can I buy Humacyte shares from India?

It is very easy to buy Humacyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Humacyte (HUMA) be purchased?

Yes, you can buy fractional shares of Humacyte with INDmoney app.

What are the documents required to start investing in Humacyte stocks?

To start investing in Humacyte, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Humacyte Stock (HUMA)?

Today’s highest price of Humacyte (HUMA) is $3.25.

Today’s lowest price of Humacyte (HUMA) is $3.02.

What is today's market capitalisation of Humacyte?

Today's market capitalisation of Humacyte HUMA is 411.7M

What is the 52 Week High and Low Range of Humacyte Stock (HUMA)?

  • 52 Week High

    $9.97

  • 52 Week Low

    $2.81

What are the historical returns of Humacyte (HUMA)?

  • 1 Month Returns

    -27.92%

  • 3 Months Returns

    -42.52%

  • 1 Year Returns

    -6.53%

  • 5 Years Returns

    -12.5%

Who is the Chief Executive Officer (CEO) of Humacyte ?

Dr. Laura E. Niklason M.D., Ph.D. is the current Chief Executive Officer (CEO) of Humacyte.

Discover More